Graphite Bio Pauses Lead Gene Editing Program in Sickle Cell Disease

Hum Gene Ther. 2023 Feb;34(3-4):90-93. doi: 10.1089/hum.2023.29234.bfs.
No abstract available

Publication types

  • News

MeSH terms

  • Anemia, Sickle Cell* / genetics
  • Anemia, Sickle Cell* / therapy
  • CRISPR-Cas Systems
  • Gene Editing
  • Graphite*
  • Humans

Substances

  • Graphite